Incidence of acute rheumatic fever in northern and western Uganda: a prospective, population-based study. Issue 10 (October 2021)

• Record Type: Journal Article
• Authors: Okello, Emmy; Ndagire, Emma; Muhamed, Babu; Sarnacki, Rachel; Murali, Meghna; Pulle, Jafesi; Atala, Jenifer; Bowen, Asha C; DiFazio, Marc P; Nakitto, M G; Harik, Nada S; Kansiime, Rosemary; Longenecker, Chris T; Lwabi, Peter; Agaba, Collins; Norton, Scott A; Omara, Isaac Otim; Oyella, Linda Mary; Parks, Tom; Rwebembera, Joselyn; Spurney, Christopher F; Stein, Elizabeth; Tochen, Laura; Watkins, David; Zimmerman, Meghan; Carapetis, Jonathan R; Sable, Craig A; Beaton, Andrea
• Is Part Of: Lancet. Volume 9:Issue 10(2021)
• Page Start: e1423
• Page End: e1430
• Publication Date: 2021-10
• Subjects: World health -- Periodicals; 362.105
• DOI: 10.1016/S2214-109X(21)00288-6
• Languages: English
• ISSNs: 2214-109X

Abstract

Summary: Background: Acute rheumatic fever is infrequently diagnosed in sub-Saharan African countries despite the high prevalence of rheumatic heart disease. We aimed to determine the incidence of acute rheumatic fever in northern and western Uganda. Methods: For our prospective epidemiological study, we established acute rheumatic fever clinics at two regional hospitals in the north (Lira district) and west (Mbarara district) of Uganda and instituted a comprehensive acute rheumatic fever health messaging campaign. Communities and health-care workers were encouraged to refer children aged 3–17 years, with suspected acute rheumatic fever, for a definitive diagnosis using the Jones Criteria. Children were referred if they presented with any of the following: (1) history of fever within the past 48 h in combination with any joint complaint, (2) suspicion of acute rheumatic carditis, or (3) suspicion of chorea. We excluded children with a confirmed alternative diagnosis. We estimated incidence rates among children aged 5–14 years and characterised clinical features of definite and possible acute rheumatic fever cases. Findings: Data were collected between Jan 17, 2018, and Dec 30, 2018, in Lira district and between June 5, 2019, and Feb 28, 2020, in Mbarara district. Of 1075 children referred for evaluation, 410 (38%) met the inclusion criteria; of these, 90 (22%) had definite acute rheumatic fever, 82 (20·0%) had possible acute rheumatic fever, and 24 (6%) had rheumatic heart disease without evidence of acute rheumatic fever. Additionally, 108 (26%) children had confirmed alternative diagnoses and 106 (26%) had an unknown alternative diagnosis. We estimated the incidence of definite acute rheumatic fever among children aged 5–14 years as 25 cases (95% CI 13·7–30·3) per 100 000 person-years in Lira district (north) and 13 cases (7·1–21·0) per 100 000 person-years in Mbarara district (west). Interpretation: To the best of our knowledge, this is the first population-based study to estimate the incidence of acute rheumatic fever in sub-Saharan Africa. Given the known rheumatic heart disease burden, it is likely that only a proportion of children with acute rheumatic fever were diagnosed. These data dispel the long-held hypothesis that the condition does not exist in sub-Saharan Africa and compel investment in improving prevention, recognition, and diagnosis of acute rheumatic fever. Funding: American Heart Association Children's Strategically Focused Research Network Grant, THRiVE-2, General Electric, and Cincinnati Children's Heart Institute Research Core.